Stay updated on MK-3475 in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the MK-3475 in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 in Brain Metastases Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a completed Phase 2 study of MK-3475 (pembrolizumab) in melanoma and non-small-cell lung cancer patients with untreated brain metastases is now displayed instead of an error page. It includes the study design and outcome measures, participant criteria, results-related publications, and study documents.
    Difference
    50%
    Check dated 2026-11-07T14:45:21.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:25:47.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:15:34.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label on the 403 access-denied page changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T18:10:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T19:10:35.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page content is replaced by a 403 Forbidden error page. The page displays a standard header/footer with an access-denied message indicating the resource cannot be accessed.
    Difference
    19%
    Check dated 2026-09-19T19:05:55.000Z thumbnail image

Stay in the know with updates to MK-3475 in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 in Brain Metastases Clinical Trial page.